The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics

J. W. Lindsey, T. F. Scott, S. G. Lynch, S. S. Cofield, F. Nelson, R. Conwit, T. Gustafson, G. R. Cutter, J. S. Wolinsky, F. D. Lublin

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics'. Together they form a unique fingerprint.

Medicine & Life Sciences